Live feed
Filing
SC 13D
SC 13D0001839882-23-014903·DMK PHARMACEUTICALS Corp
Schedule 13D ownership disclosure
Adamis Pharmaceuticals Corp
Security class unavailable · CUSIP: 00547W208
Event date: 2023-05-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 288,824
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-23-014903
- Form type
- SC 13D
- Filer
- DMK PHARMACEUTICALS Corp
- CIK
- CIK 887247
- Filed
- Jun 05, 2023
- Reporting period
- May 25, 2023
- Description
- Schedule 13D beneficial ownership